Cancer Genome Atlas project yields possible breakthrough

07/19/2012 | New York Times (tiered subscription model), The

More than 200 researchers studying 224 tumors may have found a genetic vulnerability in colon cancer that could lead to targeted treatments, according to a paper published in the journal Nature. Scientists plan to test drugs already approved for other cancers that share the genetic aberration. The research is part of the Cancer Genome Atlas project, funded by the National Cancer Institute and the National Human Genome Research Institute.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX